U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks

RenovoRx

Market Cap: US$35.2m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

Stevanato Group

Market Cap: US$6.3b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Barinthus Biotherapeutics

Market Cap: US$45.6m

A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.

Exicure

Market Cap: US$35.4m

Does not have significant operations.

Vanda Pharmaceuticals

Market Cap: US$279.5m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

PharmaCyte Biotech

Market Cap: US$6.4m

A biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States.

Nurix Therapeutics

Market Cap: US$714.0m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Evoke Pharma

Market Cap: US$11.4m

Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

Cassava Sciences

Market Cap: US$110.1m

A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.

Qiagen

Market Cap: US$10.1b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Atossa Therapeutics

Market Cap: US$98.5m

Operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States.

HilleVax

Market Cap: US$103.4m

A clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States.

GH Research

Market Cap: US$837.4m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.

Monopar Therapeutics

Market Cap: US$210.7m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

4D Molecular Therapeutics

Market Cap: US$287.7m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

MEI Pharma

Market Cap: US$159.6m

A clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.

Anbio Biotechnology

Market Cap: US$2.0b

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Silence Therapeutics

Market Cap: US$227.2m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Aldeyra Therapeutics

Market Cap: US$349.8m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Kyverna Therapeutics

Market Cap: US$160.4m

Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases.

Bone Biologics

Market Cap: US$3.9m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

InMed Pharmaceuticals

Market Cap: US$4.4m

A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.

Dianthus Therapeutics

Market Cap: US$758.7m

A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

Protara Therapeutics

Market Cap: US$120.4m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Intellia Therapeutics

Market Cap: US$1.2b

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

Applied Therapeutics

Market Cap: US$71.0m

A clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States.

Sagimet Biosciences

Market Cap: US$244.2m

A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States.

ACADIA Pharmaceuticals

Market Cap: US$4.4b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Lantern Pharma

Market Cap: US$44.1m

Focuses on the discovery and development of oncology drug.

Vaxcyte

Market Cap: US$4.0b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

OS Therapies

Market Cap: US$76.2m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Propanc Biopharma

Market Cap: US$38.5m

A development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.

Context Therapeutics

Market Cap: US$75.4m

A biopharmaceutical company, develops products for the treatment of solid tumors.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

China SXT Pharmaceuticals

Market Cap: US$169.4m

A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.

Passage Bio

Market Cap: US$22.7m

A genetic medicines company, develops gene therapies for central nervous system diseases.